Das A, Tang W Y, Smith D R
Department of Neurology, National Neuroscience Institute, Singapore, Republic of Singapore.
J Neurooncol. 2000 Apr;47(2):153-60. doi: 10.1023/a:1006484829159.
We sought to determine the relative incidence of meningiomas compared to other central nervous system tumours in an Asian surgical series, as well as the demographic and biological characteristics of these meningiomas. A review of 655 consecutive cases of central nervous system tumours from 583 patients representing the last five years admissions to one hospital in Singapore was undertaken. A total of 33 malignant/atypical tumours from 19 patients and 196 benign meningiomas from 187 patients were identified. Twenty malignant/atypical and 20 benign tumours were selected at random and subjected to histochemical and immunohistochemical analysis using antibodies directed against p53, bax and 3'-DNA hydroxy groups (TUNEL). Meningiomas comprised some 35.2% of all central nervous system tumours with malignant/atypical meningiomas representing 9.2% of meningiomas. Histochemically, necrosis was the predominant finding. However, peri-necrotic areas displayed p53 positivity in 10% of cases and bax positivity in 25% of cases. Apoptotic cells were detected in the peri-necrotic areas in 90% of benign and 75% of malignant/atypical meningiomas. Meningiomas represent the predominant form of central nervous system tumour in the Singaporean population, and aberration of p53 expression is not associated with tumour formation or progression. There was a slight but non-significant reduction in apoptosis in the progression from benign to malignant meningioma, suggesting that in contrast to many other tumour types disruption of cellular apoptosis is not a predominant driving force in Asian meningioma tumourigenesis.
我们试图确定在一个亚洲手术系列中,脑膜瘤相对于其他中枢神经系统肿瘤的相对发病率,以及这些脑膜瘤的人口统计学和生物学特征。我们回顾了新加坡一家医院过去五年收治的583例患者的655例连续中枢神经系统肿瘤病例。共识别出19例患者的33例恶性/非典型肿瘤和187例患者的196例良性脑膜瘤。随机选择20例恶性/非典型肿瘤和20例良性肿瘤,使用针对p53、bax和3'-DNA羟基(TUNEL)的抗体进行组织化学和免疫组织化学分析。脑膜瘤约占所有中枢神经系统肿瘤的35.2%,其中恶性/非典型脑膜瘤占脑膜瘤的9.2%。组织化学检查发现,坏死是主要表现。然而,坏死周边区域在10%的病例中显示p53阳性,在25%的病例中显示bax阳性。在90%的良性脑膜瘤和75%的恶性/非典型脑膜瘤的坏死周边区域检测到凋亡细胞。脑膜瘤是新加坡人群中枢神经系统肿瘤的主要形式,p53表达异常与肿瘤形成或进展无关。从良性脑膜瘤到恶性脑膜瘤的进展过程中,凋亡略有减少但无统计学意义,这表明与许多其他肿瘤类型不同,细胞凋亡的破坏不是亚洲脑膜瘤肿瘤发生的主要驱动力。